Rare lephants
Screener

Northwest Biotherapeutics, Inc.

NWBO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 14, 2025 10-Q
424B5 Jul 1, 2025 424B5
10-Q May 15, 2025 10-Q
10-K Mar 31, 2025 10-K
424B5 Dec 26, 2024 424B5
8-K Dec 26, 2024 FORM 8-K
10-Q Nov 12, 2024 10-Q
8-K Nov 1, 2024 FORM 8-K
4 Sep 3, 2024 OWNERSHIP DOCUMENT
4 Aug 13, 2024 OWNERSHIP DOCUMENT
10-Q Aug 9, 2024 10-Q
4 Aug 8, 2024 OWNERSHIP DOCUMENT
8-K Aug 2, 2024 FORM 8-K
4 Jul 30, 2024 OWNERSHIP DOCUMENT
8-K Jul 3, 2024 FORM 8-K
DEFA14A Jun 25, 2024 DEFA14A
8-K Jun 4, 2024 FORM 8-K
DEF 14A Jun 3, 2024 DEF 14A
PRE 14A May 22, 2024 PRE 14A
10-Q May 10, 2024 10-Q
8-K May 2, 2024 FORM 8-K
10-K/A Apr 29, 2024 FORM 10-K/A
8-K Mar 22, 2024 FORM 8-K
8-K Mar 14, 2024 FORM 8-K
10-K Mar 5, 2024 10-K
← Newer Page 2 of 33 · 803 filings Older →